Lionsbridge Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Lionsbridge Wealth Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36,244	Closed	-$1.49M	–	52
2023 Q1	$1.49M	Sell	36,244 -943	-3%	-$39.6K	1.37%	28
2022 Q4	$1.52M	Buy	37,187 +10,217	+38%	+$425K	1.48%	25
2022 Q3	$1.08M	Buy	26,970 +496	+2%	+$21.2K	1.55%	20
2022 Q2	$1.11M	Sell	26,474 -2,037	-7%	-$85.4K	1.28%	24
2022 Q1	$1.29M	Sell	28,511 -1,069	-4%	-$47K	1.49%	32
2021 Q4	$1.36M	Sell	29,580 -317	-1%	-$15K	1.47%	37
2021 Q3	$1.42M	Sell	29,897 -77	-0.3%	-$3.83K	1.53%	35
2021 Q2	$1.55M	Buy	29,974 +6,667	+29%	+$335K	1.66%	20
2021 Q1	$1.17M	Buy	23,307 +898	+4%	+$47.9K	1.14%	41
2020 Q4	$1.17M	Buy	22,409 +887	+4%	+$42.4K	1.26%	34
2020 Q3	$935K	Buy	21,522 +4,678	+28%	+$205K	1.12%	33
2020 Q2	$723K	Buy	+16,844	New	+$696K	0.81%	39

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lionsbridge Wealth Management's XPH Position: Q2 2023 in Review

Lionsbridge Wealth Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2023, closing a stake of 36,244 shares — an estimated $1.49M sold.

Lionsbridge Wealth Management first reported a position in XPH in Q2 2020 and held it in 12 quarters. The position peaked at $1.55M in Q2 2021. 59 funds tracked by Wall St. Rank hold XPH as of Q2 2023.

Lionsbridge Wealth Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Lionsbridge Wealth Management sold 36,244 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2023, an estimated $1.49M.
Lionsbridge Wealth Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2020 and held it in 12 quarters.
Lionsbridge Wealth Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.55M in Q2 2021.
59 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2023.

Based on Lionsbridge Wealth Management's 13F filing for Q2 2023, filed 31 Jul 2023.